Finnrick - Ensuring a Safer and More Transparent Supply Chain
Hangzhou Youngpeptide Biotechnology HYB

Hangzhou Youngpeptide Biotechnology HYB
Retatrutide

Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Hangzhou Youngpeptide Biotechnology HYB between 5 Aug 2025 and 23 Dec 2025. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).

Finnrick Rating™
E
BAD
Hangzhou Youngpeptide Biotechnology HYB
Retatrutide
Tested 6 Samples
Last test 23 Dec 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Retatrutide tests from Hangzhou Youngpeptide Biotechnology HYB

Samples are tested in commercial labs

Tests Count

6

Scores

AVG5.2MIN0.0MAX8.0

Last

23 Dec 2025

First

5 Aug 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
23 Dec 2025View8.030mg30.3mg+1.0%99.95%(no batch ID)(no data)Lab EPublic
17 Dec 2025View7.410mg9.8mg-2.0%99.66%(no batch ID)White Label / Copper Crimp / Clear CapLab EPublic
13 Dec 2025View4.120mg31.1mg+55.5%99.70%(no batch ID)No Label / Silver Crimp / Clear Blue CapLab GPublic
13 Dec 2025View6.830mg31.4mg+4.7%99.40%(no batch ID)White Label / Silver Crimp / Blue CapLab GPublic
10 Dec 2025View0.010mg
⚠️ Sample does not contain Retatrutide
(no batch ID)No Label / Silver Crimp / Blue CapLab GPublic
5 Aug 2025View4.85mg5.51mg+10.2%99.20%(no batch ID)Clear Label / Silver Crimp / Grey CapLab DPublic